AnHeart Therapeutics Announces Exclusive License Agreement With Nippon Kayaku for Taletrectinib in Japan
NEW YORK--(BUSINESS WIRE)--AnHeart Therapeutics (“AnHeartâ€), a global clinical-stage biopharmaceutical company developing novel precision therapies for…